NextGen Healthcare, Inc.
NXGN · NASDAQ
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | $653,172 | $596,350 | $556,821 | $540,239 |
| % Growth | 9.5% | 7.1% | 3.1% | – |
| Cost of Goods Sold | $342,013 | $295,404 | $275,424 | $267,439 |
| Gross Profit | $311,159 | $300,946 | $281,397 | $272,800 |
| % Margin | 47.6% | 50.5% | 50.5% | 50.5% |
| R&D Expenses | $82,300 | $76,657 | $75,501 | $83,295 |
| G&A Expenses | $213,154 | $202,881 | $176,627 | $159,130 |
| SG&A Expenses | $223,424 | $209,661 | $180,529 | $165,174 |
| Sales & Mktg Exp. | $10,270 | $6,780 | $3,902 | $6,044 |
| Other Operating Expenses | $3,665 | $3,525 | $4,449 | $4,143 |
| Operating Expenses | $309,389 | $289,843 | $260,479 | $252,612 |
| Operating Income | $16,238 | $11,140 | $20,892 | $21,290 |
| % Margin | 2.5% | 1.9% | 3.8% | 3.9% |
| Other Income/Exp. Net | $8,170 | -$5,944 | -$10,276 | -$14,979 |
| Pre-Tax Income | $4,304 | $5,196 | $9,275 | $4,259 |
| Tax Expense | $6,958 | $3,578 | -$240 | -$3,239 |
| Net Income | -$2,654 | $1,618 | $9,515 | $7,498 |
| % Margin | -0.4% | 0.3% | 1.7% | 1.4% |
| EPS | -0.04 | 0.02 | 0.14 | 0.11 |
| % Growth | -300% | -85.7% | 27.3% | – |
| EPS Diluted | -0.04 | 0.02 | 0.14 | 0.11 |
| Weighted Avg Shares Out | 66,350 | 67,370 | 66,739 | 65,474 |
| Weighted Avg Shares Out Dil | 67,005 | 67,788 | 66,885 | 65,612 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,541 | $101 | $38 | $256 |
| Interest Expense | $6,298 | $1,499 | $3,516 | $1,955 |
| Depreciation & Amortization | $36,694 | $42,315 | $49,214 | $4,143 |
| EBITDA | $48,044 | $53,455 | $70,106 | $25,433 |
| % Margin | 7.4% | 9% | 12.6% | 4.7% |